"Efficacy and Safety of Single Low-Dose Intravenous Ketamine for Postherpetic Neuralgia With Depression: A Randomized Controlled Study
Phase: PHASE4 | Sponsor: Huazhong University of Science and Technology | Compound: Ketamine
- Status
- planned
- Institution
- Huazhong University of Science and Technology
- Start date
- 2025-06-15
- End date
- 2026-06-01
- Registry ID
- NCT06968624
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.